Lumenis, which develops and sells laser-based systems used in minimally invasive surgical, ophthalmic and aesthetic procedures, filed on Friday with the SEC to raise up to $115 million in an initial public offering. The Yokneam, Israel-based company, which was founded in 1991 and booked $261 million in sales for the 12 months ended September 30, 2013, plans to list on the NASDAQ under the symbol LMNS. Goldman Sachs, Credit Suisse, Jefferies and Wells Fargo Securities are the joint bookrunners on the deal. No pricing terms were disclosed.
